Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

ConditionsProstate Cancer Prostate Cancer (Diagnosis)Prostate Cancer (Post Prostatectomy)Prostate Cancer Patients Treated by Radiotherapy Prostate Cancer Metastatic Prostate Cancer (Adenocarcinoma)

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexMale

Age19+

SponsorSociété Algérienne de Formation et Recherche en Oncologie

About this trial

The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer.

It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.

Eligibility criteria

Qualifiers

Patients aged 19 years and older.

Diagnosis of prostate cancer confirmed histologically and/or biologically.

Patients followed in the participating oncology departments.

Written informed consent obtained.

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

CAC Adrar - Oncology Department01000, AdrarAlgeria, Algeria

CAC Adrar - Radiotherapy Department01000, AdrarAlgeria, Algeria

CAC BLIDA - Oncology Department16000, AlgiersAlgeria, Algeria

Centre Pierre et Marie Curie - Oncology Department16000, AlgiersAlgeria, Algeria

Sponsors and collaborators

Société Algérienne de Formation et Recherche en Oncologie

Lead sponsor

ES Clinical Research

Collaborator

Ipsen

Collaborator

Astellas Pharma Inc

Collaborator

Source ClinicalTrials.gov